Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 52 pages

Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2013” provides data on the Nerviano Medical Sciences S.r.l.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Nerviano Medical Sciences S.r.l.’s corporate website, SEC filings, investor presentations and featured press releases, both from Nerviano Medical Sciences S.r.l. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Nerviano Medical Sciences S.r.l. - Brief Nerviano Medical Sciences S.r.l. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nerviano Medical Sciences S.r.l. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nerviano Medical Sciences S.r.l. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nerviano Medical Sciences S.r.l.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Nerviano Medical Sciences S.r.l.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nerviano Medical Sciences S.r.l. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences S.r.l.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nerviano Medical Sciences S.r.l..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nerviano Medical Sciences S.r.l. and identify potential opportunities in those areas.

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Nerviano Medical Sciences S.r.l. Snapshot 6
Nerviano Medical Sciences S.r.l. Overview 6
Key Information 6
Key Facts 6
Nerviano Medical Sciences S.r.l. - Research and Development Overview 7
Key Therapeutic Areas 7
Nerviano Medical Sciences S.r.l. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Nerviano Medical Sciences S.r.l. - Pipeline Products Glance 14
Nerviano Medical Sciences S.r.l. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Nerviano Medical Sciences S.r.l. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Nerviano Medical Sciences S.r.l. - Drug Profiles 18
danusertib 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
milciclib 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
nemorubicin 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
NMS-E628 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
NMS-1116354 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
NMS-1286937 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
NMS-616 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
NMS-P118 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
NMS-P153 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
NMS-P285 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
NMS-P506 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
NMS-P626 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
NMS-P648 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
NMS-P715 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
NMS-P914 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
NMS-P948 34
Product Description 34
Mechanism of Action 34
RandD Progress 34
NMSE-973 35
Product Description 35
Mechanism of Action 35
RandD Progress 35
PHA-793887 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
RET Inhibitor Program 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
NMS-873 38
Product Description 38
Mechanism of Action 38
RandD Progress 38
VCP Inhibitors Program 39
Product Description 39
Mechanism of Action 39
RandD Progress 39
Nerviano Medical Sciences S.r.l. - Pipeline Analysis 40
Nerviano Medical Sciences S.r.l. - Pipeline Products by Therapeutic Class 40
Nerviano Medical Sciences S.r.l. - Pipeline Products by Target 41
Nerviano Medical Sciences S.r.l. - Pipeline Products by Route of Administration 43
Nerviano Medical Sciences S.r.l. - Pipeline Products by Molecule Type 44
Nerviano Medical Sciences S.r.l. - Pipeline Products by Mechanism of Action 45
Nerviano Medical Sciences S.r.l. - Recent Pipeline Updates 47
Nerviano Medical Sciences S.r.l. - Dormant Projects 49
Nerviano Medical Sciences S.r.l. - Locations And Subsidiaries 50
Head Office 50
Appendix 51
Methodology 51
Coverage 51
Secondary Research 51
Primary Research 51
Expert Panel Validation 51
Contact Us 52
Disclaimer 52



List of Tables

Nerviano Medical Sciences S.r.l., Key Information 6
Nerviano Medical Sciences S.r.l., Key Facts 6
Nerviano Medical Sciences S.r.l. - Pipeline by Indication, 2013 8
Nerviano Medical Sciences S.r.l. - Pipeline by Stage of Development, 2013 10
Nerviano Medical Sciences S.r.l. - Monotherapy Products in Pipeline, 2013 11
Nerviano Medical Sciences S.r.l. - Out-Licensed Products in Pipeline, 2013 12
Nerviano Medical Sciences S.r.l. - Out-Licensed Products/ Combination Treatment Modalities, 2013 13
Nerviano Medical Sciences S.r.l. - Phase II, 2013 14
Nerviano Medical Sciences S.r.l. - Phase I, 2013 15
Nerviano Medical Sciences S.r.l. - Preclinical, 2013 16
Nerviano Medical Sciences S.r.l. - Discovery, 2013 17
Nerviano Medical Sciences S.r.l. - Pipeline by Therapeutic Class, 2013 40
Nerviano Medical Sciences S.r.l. - Pipeline by Target, 2013 42
Nerviano Medical Sciences S.r.l. - Pipeline by Route of Administration, 2013 43
Nerviano Medical Sciences S.r.l. - Pipeline by Molecule Type, 2013 44
Nerviano Medical Sciences S.r.l. - Pipeline Products by Mechanism of Action, 2013 46
Nerviano Medical Sciences S.r.l. - Recent Pipeline Updates, 2013 47
Nerviano Medical Sciences S.r.l. - Dormant Developmental Projects,2013 49



List of Figures

Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Indication, 2013 8
Nerviano Medical Sciences S.r.l. - Pipeline by Stage of Development, 2013 10
Nerviano Medical Sciences S.r.l. - Monotherapy Products in Pipeline, 2013 11
Nerviano Medical Sciences S.r.l. - Out-Licensed Products in Pipeline, 2013 12
Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Therapeutic Class, 2013 40
Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Target, 2013 41
Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Route of Administration, 2013 43
Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Molecule Type, 2013 44
Nerviano Medical Sciences S.r.l. - Pipeline Products by Top 10 Mechanism of Action, 2013 45



Companies Mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Biogen Idec Inc. - Product Pipeline Review - 2014

Biogen Idec Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Biogen Idec Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Biogen Idec Inc. - Product Pipeline Review - 2014', provides an overview of the Biogen Idec Inc.'s pharmaceutical research ...

Drug and Medication Industry: Celgene Corporation – Product Pipeline Review – Q4 2010

Drug and Medication Industry: Celgene Corporation – Product Pipeline Review – Q4 2010

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Therametrics holding AG - Product Pipeline Review - 2014

Therametrics holding AG - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Therametrics holding AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Therametrics holding AG - Product Pipeline Review - 2014', provides an overview of the Therametrics holding ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.